Monocyte-to-HDL Ratio (MHR)
Here’s what it reflects — and what to do about it.
Longetic pulls together every lab and record you’ve had, follows how Monocyte-to-HDL Ratio (MHR) changes over time, and explains what’s shifting — so you walk into your next appointment prepared, with reminders for retests along the way.
What is Monocyte-to-HDL Ratio (MHR)?
A calculated ratio combining an inflammatory white-blood-cell count (monocytes) with good (HDL) cholesterol.
This is a calculated value combining two routine results: it divides your monocyte count (from a CBC) by your HDL cholesterol (from a lipid panel). Because monocytes drive inflammation and HDL helps counter it, a higher MHR can be associated with more inflammation and, in research, cardiovascular and metabolic risk, a lower value can be associated with a more favorable balance. It is a general marker, not a diagnosis.
What to know about Monocyte-to-HDL Ratio (MHR)
Understanding Monocyte-to-HDL Ratio (MHR) means knowing what it reflects, what tends to move it, and the signs that suggest it’s worth a closer look — so you can bring the right questions to your next appointment.
This glossary entry is for informational purposes only and is not a substitute for professional medical advice. Read our Medical Disclaimer.
References
About our sources
Official sources
Government health agencies, national institutes, and intergovernmental bodies whose guidelines carry regulatory or policy weight.
Clinical / professional
Medical societies, specialty colleges, and professional associations whose consensus statements reflect clinical practice standards.
Peer-reviewed research
Original research articles and systematic reviews published in indexed journals and verified through PubMed or DOI.